Stocks Health care CSBR
NASDAQ · Health careChampions Oncology, Inc. (CSBR)
Champions Oncology, Inc. brought in $60.7M of revenue over the twelve months to July 31, 2026, up 6.7% from a year earlier. It posted a net loss of $1.1M. In fiscal 2026 capital spending exceeded operating cash flow by $5M. At July 31, 2026 it held $4.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on September 11, 2026.
What Champions Oncology, Inc. does
Champions Oncology, Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker CSBR.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | $59.4M | -$1.2M | -$0.08 | -$5M |
| 2025 | $56.9M | $4.7M | $0.33 | $7M |
| 2024 | $50.2M | -$7.3M | -$0.54 | -$7M |
| 2023 | $53.9M | -$5.3M | -$0.39 | $1.1M |
| 2022 | $49.1M | $548K | $0.04 | $4.1M |
| 2021 | $41M | $362K | $0.02 | -$5M |
Latest SEC filings
What Champions Oncology, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 11, 2026Quarterly report 10-Q · period to July 31, 2026
- September 10, 2026
- August 28, 2026Additional proxy material DEFA14A
- August 28, 2026Proxy statement DEF 14A
- July 27, 2026Annual report 10-K · period to April 30, 2026
- July 27, 2026
- March 30, 2026
- March 12, 2026Quarterly report 10-Q · period to January 31, 2026
- March 12, 2026
- December 15, 2025Quarterly report 10-Q · period to October 31, 2025
Questions about CSBR
What does Champions Oncology, Inc. do?
Champions Oncology, Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker CSBR.
Is Champions Oncology, Inc. profitable?
No. Over the twelve months to July 31, 2026 it reported a net loss of $1.1M on revenue of $60.7M.
How much revenue does Champions Oncology, Inc. make?
Over the twelve months to July 31, 2026 Champions Oncology, Inc. reported revenue of $60.7M. That is 6.7% more than a year earlier.
When did Champions Oncology, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on September 11, 2026. It covers the period to July 31, 2026.
Similar companies
Follow CSBR
Get an email when Champions Oncology, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow CSBR: get an email when it filesWhere the numbers come from
Financial figures are the values Champions Oncology, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.